Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal
Links shared publicly online about this topic.
- 725total visits
Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal
Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.
View full resource at news-medical.net
Most Recently Shared on November 15, 2010 at 2:13 pm By:
Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal: Talecris Biot... http://bit.ly/c6hMtu
Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal
news-medical.net — “Talecris Biotherapeutics announced today the publication of combined data from two studies demonstrating that augmentation therapy with Alpha(1)-Proteinase Inhibitor (Human) (A1PI) significantly reduces lung tissue loss in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency.” View full resource at news-medical.net
Most Recently Shared on November 15, 2010 at 12:46 pm By:
Talecris announces publication of A1PI studies for AAT deficiency in Respiratory Research journal: Talecris Biot... http://bit.ly/9AKYoZ
Advertisement
